Capturing the Data: Improving Patient Outcomes

Add this event to your calendar:
27/09/2017 17:00 27/09/2017 19:00 America/Los_Angeles Capturing the Data: Improving Patient Outcomes JLABS , 3210 Merryfield Row , San Diego , CA 92121 JLABS San Diego together with Janssen R&D false DD/MM/YYYY
September
27
Event

Capturing the Data: Improving Patient Outcomes

JLABS , 3210 Merryfield Row , San Diego , CA 92121

September 27, 2017 from 17:00 PM to 19:00 PM (PDT)

$10 - $35


Could the advancement of new technologies leveraging data and analytics hold the key to transforming healthcare into a more patient centric and cost efficient model? Startups are innovating in areas such as data aggregation, risk stratification, outcomes reporting and even staffing standardization – all of which have the end goal of putting more focus on enhancing patient care. The progression of the value-for-service model has also sparked development of data driven solutions capable of demonstrating improvements in patient outcomes. The role of data in patient care is expanding in so many ways - come hear players in the field discuss trends, potential impact, challenges and more.

Join Johnson & Johnson Innovation, JLABS for a discussion with experts on how data can affect patient outcomes. We’ll explore topics such as:

  • Types of data and differences in application
  • Where and how to find effective patient data
  • The benefits of data and how it influences patients
  • How data will increase the quality of healthcare
  • What it takes to improve patient outcomes


Speakers:
Guy Horton | Director of Healthcare and Science Strategy, Wondros read bio»
Brent Clough | CEO, Trio Health, Inc. read bio»
Wen Dombrowski | Chief Convergence Officer, CATALAIZE read bio»
David Jackson | CEO, EvinceMed Corp. read bio»
Silas Martin | Director, Health Care Quality Solutions, Johnson & Johnson Health Care Systems Inc. read bio»


Agenda:
3:00 PM | Registration Opens, Networking*
3:45 PM | Panel Discussion and Q&A
5:00 PM | Program Close
*Light refreshments provided

Who should attend:
Healthtech companies and startups, entrepreneurs, advisors & investors.


Fees:
$25 | General Public
$15 | Student/Academic
$35 | At the door


Location:
JLABS
3210 Merryfield Row
San Diego, CA

Speaker Biographies:
Guy Horton | Director of Healthcare and Science Strategy, Wondros
As director of healthcare and science strategy at Wondros, Guy uniquely blends his background in the humanities and social sciences, journalism, and innovation design to create communications and interactions that help researchers, clinical teams, and patients more effectively achieve their goals. Guy’s strategy and storytelling capabilities have been central to a number of health and science initiatives, including the NIH’s All of Us Research Program, part of the landmark Precision Medicine Initiative and the University of Pittsburgh Clinical and Translational Science Institute’s Pitt+Me program, which transforms the way people engage with biomedical research. Guy is passionate about the power of empathetic, human-centered storytelling and design as a way to explore new opportunities for positive change and action. Through design research, he helps conceptualize and lead the development of digital and non-digital tools, platforms, and experiences to enhance people’s interactions and optimize outcomes.


Brent Clough | CEO, Trio Health, Inc.
Brent Clough co-founded Trio Health in 2013. Trio Health provides MFRs with real-time insight on real-world patients along with auditing the performance of physicians and pharmacies. Prior to Trio Health, Brent founded IntrinsiQ Financial in 2004, which merged with IntrinsiQ Research in 2006. IntrinsiQ developed a robust Oncology platform to allow MFRs and hedge funds to understand usage by stage, line and disease that reconciled to reported drug revenue. Upon the merger, Brent was elected President and CEO of the company. The company grew from a start-up to 90 employees prior to being acquired by Amerisource Bergen. Before entering the healthcare industry, Brent spent eight years as a Vice President at Goldman Sachs (1996-2004) working in the investment research and equities division. Prior to Goldman, Brent worked at First Call Corporation (1988-1996) within the institutional sales and broker dealer division.


Wen Dombrowski, MD, MBA | Chief Convergence Officer, CATALAIZE
Dr. Dombrowski is the founding principal of CATALAIZE, a consultancy that advises a wide range of healthcare organizations, technology companies, and investors on innovation and emerging technologies. She has also worked in technology startups, managed care, home care, nursing homes, community health centers, hospitals, and other settings along the continuum of care. Dr. Dombrowski was previously Chief Medical Information Officer (CMIO+CIO) for a state-wide homecare and community health provider, the Technology & Communications Strategy lead for a large regional integrated delivery network's Value-Based Care initiatives, Clinical Informatics Director at a multi-specialty network of community clinics, and Medical Director at a special needs managed care plan for Medicaid-Medicare dual-eligible seniors.


David Jackson | CEO, EvinceMed Corp.
David Jackson, an EDI entrepreneur in the health data industry, has over 22 years of experience in founding and growing successful healthcare information technology companies. He began his career in 1995 with one of the country’s first EDI networks, Envoy-NEIC and connected health care providers, their software vendors and health plans to networks that traded eligibility, claim and remittance data. In 1997 David founded the first commercially distributed health data network over the Internet, EpiCenter Interactive, through a product he developed known as Rapid Claims. David then founded ClaimLogic, a national EDI network that supported academic health institutions that was later sold to Gateway (TriZetto) in 2012. In 2003 he co-founded Health Data Logistics (“HDL”), an EDI network that again pioneered EDI connectivity via Payer Web Portals in a way that allowed physicians to exchange sub-capitation data to their IPAs and move roster and encounter data between IPAs and Managed Care Organizations.


Silas Martin | Director, Health Care Quality Solutions, Johnson & Johnson Health Care Systems Inc.
Silas Martin is the Director of Health Care Quality Solutions for Johnson & Johnson Health Care Systems Inc. In this role, he leads a team to design and implement quality improvement partnerships with health plans and health systems in pursuit of the Triple Aim. To support these projects, Johnson & Johnson Health Care Systems provides solutions designed to address common challenges in the evolving healthcare marketplace, which can be implemented individually or with existing care delivery processes. The team also works with stakeholders in the broader quality enterprise to support the further advancement of quality measurement and improvement.




JLABS San Diego together with Janssen R&D

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content